PS962 PHASE 1 RESULTS OF ZUMA‐4: KTE‐X19, AN ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBL... von Wayne, A.S., Huynh, V., Hijiya, N., Rouce, R., Brown, P.A., Krueger, J., Rytting, M., Kitko, C.L., Dela Ziga, E., Hermiston, M., Richards, M.K., Baruchel, A., Shen, T., Goyal, L., Vezan, R., Jain, R., Lee, D.W.

Volltext

Hematopoeitic Cell Transplant (HCT) Survivorship: How Much Variance in Depressive Symptoms Can Be Accounted for by Biomedical Variables? von Kitko, C.L, Zhao, L, Carey, J, Gourley, B, Richard, A, Proudfoot, S, Mineishi, S, Couriel, D.R, Levine, J.E, Riba, M, Hoodin, F

Volltext

Extramedullary Relapse In Acute Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors And Outcomes von Harris, A.C, Mageneau, J, Braun, T, Kitko, C.L, Choi, S.W, Ferrara, J.L.M, Mineishi, S, Pawarode, A, Peres, E, Reddy, P, Yanik, G, Levine, J.E

Volltext

Day7 TNFR1 Levels Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HCT) Predict For Acute GVHD von Kitko, C.L, Mineishi, S, Braun, T, Choi, S.W, Jones, D, Harris, A, Khaled, Y, Krijanovski, O, Paczesny, S, Peres, E, Yanik, G, Whitfield, J, Ferrara, J.L, Levine, J.E

Volltext

Elafin is a Biomarker of Graft Versus Host Disease of the Skin von Paczesny, S, Levine, J.E, Hogan, J, Crawford, J, Braun, T.M, Wang, H, Faca, V, Zhang, Q, Pitteri, S, Chin, A, Choi, S.W, Kitko, C.L, Krijanovski, O.I, Reddy, P, Mineishi, S, Whitfield, J, Jones, D, Hanash, S.M, Ferrara, J.L.M

Volltext

29: Addition of Etanercept to Methylprednisolone as Initial Therapy for Acute GVHD Results in High Response Rates and Improved Survival von Levine, J.E, Paczesny, S, Mineishi, S, Braun, T, Choi, S.W, Hutchinson, R.J, Jones, D, Khaled, Y, Kitko, C.L, Bickley, D, Krijanovski, O, Reddy, P, Yanik, G, Ferrara, J.L.M

Volltext